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The proliferation of T lymphocytes requires a lymphokine, T cell growth
factor (TCGF) or interleukin 2, together with the ability of the cells to respond
to its signal . Several studies have shown that responsiveness to the growth factor
is acquired during antigen or lectin stimulation (1-4) . In fact, the presence of a
cell surface receptor for the factor was implied by the ability of cells to absorb
TCGF bioactivity (4) . Direct demonstration of a specific, high affinity receptor
was later made using pure, biosynthetically radiolabeled growth factor (5) . As
expected, binding of labeled TCGF was largely restricted to antigen or lectin-
activated T cells . Recently, Leonard and co-workers (6) demonstrated that a
murine monoclonal antibody, termed anti-Tac (7), was able to block the binding
of labeled TCGF to a receptor-positive, human T cell line, HUT102B2 . The
antibody bound a major component of 47,000-53,000 mol wt (designated p50)
and minor components of 113,000 and 180,000 mol wt from detergent-solubi-
lized cells . Similar experiments on phytohemagglutinin (PHA)-activated normal
lymphocytes demonstrated that the antibody recognized a slightly larger mole-
cule of 52,000-57,000 cool wt (designated p55) .' Although the data suggested
that one of these components contained the binding site for TCGF, it was
impossible to ascertain which one was responsible . Moreover, it remained possible
that the anti-Tac-reactive molecules were unrelated to the TCGF receptor and
merely associated with it on the cell surface . In this paper, we demonstrate that
the p55 molecule that is recognized by anti-Tac is itself able to bind directly to
TCGF . This molecule thus appears to represent the cellular TCGF receptor .
Materials and Methods
Cell Labeling.
￿
Human peripheral blood lymphocytes were isolated using Ficoll-Paque
(Pharmacia Fine Chemicals, Piscataway, NJ) and were cultured (1 X 106 cells/ml initial
concentration) at 37°C in RPMI 1640 containing 10% fetal bovine serum and 1 jug/ml
PHA (HA-16 ; Burroughs Wellcome Co ., Research Triangle Park, NC) . After 3 d, blast
cells were isolated on a step gradient of Percoll (Pharmacia Fine Chemicals) (8) . For
labeling with ["S]methionine, the cells were resuspended at 3 X 106 cells/ml in methionine-
free minimum essential medium (MEM) (Gibco Laboratories, Grand Island, NY) with 1%
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fetal bovine serum, I U/ml immunoaffinity-purified TCGF, and 100 ,Ci/ml [35S]methi-
onine (1244.5 Ci/mmol ; New England Nuclear, Boston, MA) . The cells were harvested
after 8 h at 37°C . For labeling with [ 3H]glucosamine, the blast cells were resuspended at
2 x 10" cells/nil in RPMI 1640, 10% fetal bovine serum with 1 U/ml TCGF and 20,uCi/
ml ['H]glucosamine (32.5 Ci/mmol ; New England Nuclear) . The cells were harvested
after 16 h at 37°C .
Solubilization .
￿
Radiolabeled blast cells (100 X 10') were solubilized by resuspension in
1 .0 ml of 10 rnM Tris, pH 7.5, 0 .5% Nonidet P-40 (NP-40 ; Sigma Chemical Co ., St.
Louis, MO), 5 MM MgCl2, and 2 AM phenylmethylsulfonyl fluoride (Sigma Chemical
Co.) . After 30 min at 0 ° C, the mixture was centrifuged at 100,000 g for 60 min . The
supernatant was stored at -70°C .
Cell Binding.
￿
The inhibition of cellular binding of biosynthetically labeled, immunoaf-
finity-purified TCGF (9) by anti-Tac was measured bZ incubating (20 min, 37°C) serial
dilutions of the antibody with radiolabeled factor ([ . H]leucine, lysine TCGF [5]) and
human PHA-blast cells (72 h culture) . The amount of TCGF added was chosen to give
90% of the maximum binding to high affinity receptors . The cells were added at the
initiation of the incubation rather than being pretreated with antibody (6) . After incuba-
tion, the cells were washed and the binding levels of TCGF measured as previously
described (5) .
T (:ell Growth Factor.
￿
TCGF was obtained from supernatants of the human T cell line,
Jurkat, after stimulation of the cells with PHA and phorbol myristic acetate (10) . The
factor was enriched to 99+% purity using an immunoaffinity column coupled with a
murine monoclonal antibody (9) .
.4ffinit11 Supports .
￿
Purified anti-Tac antibody was coupled to cyanogen bromide-acti-
vated Sepharose 4B (Sigma Chemical Co .) by mixing a solution of antibody (1 mg/ml in
0 .1 M NaHCO :;, pH 8.2) with an equal volume of beads for 3 h at 4° . The reaction was
quenched by the addition of 0 .1 vol 0.2 M glycine, 0.1 M NaHC03 , pH 8.2 . Purified
TCGF was coupled to Affigel 10 (Bio-Rad Laboratories, Richmond, CA) by mixing a
solution of factor (1 mg/ml in 0.1 M Hepes, pH 7.2) with an equal volume of beads for 3
h at 4°C followed by quenching with glycine . In both cases, coupling efficiency exceeded
95% .
Affnit) Fractionation of Cellular Protein .
￿
Aliquots (50 Al) of detergent-soluble prepara-
tions from radiolabeled PHA-blast cells were first cleared of nonspecifically binding
material by incubation (30 min at 20°C) with 10 jl of Sepharose or Affigel 10 coupled
with 1 mg/ml control murine IgG (Sigma Chemical Co .) . The supernatant was then
incubated with anti-Tac(4 ul) or TCGF-coupled beads (10 A1) for 60 min at 20°C followed
by extensive washing with 10mM Tris, pH 7.5, 0.14 M NaCl . For sequential analysis, the
supernatant of the first incubation was reacted with a second fresh sample of anti-Tac or
TCGF-coupled beads . Bound protein was recovered by boiling the washed beads for 5
min in sodium dodecyl sulfate (SDS) sample buffer (100,1).
Gel Electrophoresis .
￿
Labeled molecules were analyzed by SDS-polyacrylamide gel elec-
trophoresis (PAGE) (8.75% acrylamide) according to the method of Laemmli (11) .
Radioactivity was visualized by fluorography using Enhance (New England Nuclear) .
Results and Discussion
As previously shown by Leonard et al . (6) using the HUT 102B2 cell line, the
anti-Tac antibody was able to totally inhibit the high affinity binding (Kd-3-6
X 10- ' z M) of [3H]leucine, lysine TCGF to human PHA-blast cells (Fig . 1) . When
the antibody was added to the culture at the same time as the growth factor, an
-50-fold molar excess of antibody over TCGF was required to achieve 50%
inhibition of binding . Since the high affinity binding was directly correlated with
the proliferative response of the cells (5), anti-Tac appeared to recognize a
component of the physiological receptor or an associated cell surface molecule .
To directly compare TCGF-binding and anti-Tac-reactive molecules, deter-1334
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FIGURE 1 .
￿
Inhibition by the anti-Tac antibody of the binding of ['Hlleucine, lysine TCGF
(7 fmol/200 AI) to human PHA-blast cells.
gent-soluble preparations were made ofPHA-induced blast cellsbiosynthetically
labeled with either ["S]methionine or [sH]glucosamine. The preparations were
incubated with either TCGF-coupled Affigel or anti-Tac-coupled Sepharose
followed by SDS-PAGE analysis of the bound molecules. As shown in Fig. 2,
both TCGF and anti-Tac-coupled supports specifically bound molecules of
-58,000 mot wt from either [s5S]methionine- or [sH]glucosamine-labeled cells.
Consistent with the observations of Leonard et al. (6), the bands visualized by
fluorography were somewhat broader than those of standard proteins. The
diffuse nature of the bands may be attributable to the fact that the molecule is
highly glycosylated (12).' In addition to the band at 58,000 mot wt, a faint band
at 115,000 mot wt was occasionally detected using both TCGF and anti-Tac
affinity supports. The inconsistency of its appearance may reflect a weak inter-
action with the 58,000 cool wt molecule or poor solubilization under these
conditions.
The SDS-PAGE results suggested that the molecules recognized by anti-Tac
and those able to bind to TCGF were glycoproteins of the same size. To
demonstrate that they were identical, a preparation of [3H]glucosamine-labeled
material was subjected to sequential binding by TCGF-coupled Affigel and anti-
Tac-coupled Sepharose. Virtually all the anti-Tac-reactive material was bound
during the first incubation with anti-Tac-Sepharose (Table 1). Subjection of the
supernatant from the first incubation to reaction with a second aliquot of anti-
Tac-Sepharose resulted in the binding of little additional radiolabel. Incubation
of the supernatant froth this second reaction with TCGF-coupled Affigel also
failed to result in significant binding, indicating that TCGF-binding molecules
were included within the set of molecules bound by anti-Tac. When the converse
series of incubations were performed, very little radiolabel was bound by anti-
Tac after two successive incubations of the [3H]glucosamine-labeled material
with TCGF-coupled Affigel. Thus, the anti-Tac-reactive molecules were in-
cluded within those directly binding to a TCGF affinity support. SDS-PAGE
analysis of the molecules bound at each step confirmed that all bound radiolabel
was present in the 58,000 mot wt molecule(s) (data not shown).Sample
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TABLE I
Sequential Binding of Radiolabeled Cellular Molecules to TCGF and Anti-Tac Amity Supports
First incubation
￿
Second incubation
￿
Third incubation
TCGF Affigel
￿
Anti-Tac
￿
TCGF Affigel
￿
Anti-Tac
￿
TCGF Affigel
￿
Anti-Tac
Sepharose
￿
Sepharose
￿
Sepharose
dpYn
I - 20,100(96) - 580(3) 350(1) -
2 15,200(79) - 3,100(16) - - 900(5)
*Two identical samples (8 x 106 dpm) of NP-40-solubilized molecules from ['H]glucosamine-labeled PHA-blast
cells were subjected to three sequential incubations with TCGF-coupled Affigel (10 AI) and anti-Tac-coupled
Sepharose (4 AI) as indicated. The results are given as disintegrations per minute of ['H]radiolabel in the pellet.
Values in parentheses represent the percentage of the total bound radiolabel for the three incubations. Control
IgG-coupled Sepharose or Affigel bound <I% ofthe above values.
These results demonstrate directly that the 58,000 mol wt Tac antigen on
PHA-blast cells contains a binding site for TCGF. Furthermore, they indicate
that under these solubilization conditions, only anti-Tac-reactive molecules have
thiscapability. Inhibition ofTCGFbioactivity (6)and radiolabeled TCGFbinding
by anti-Tac can thus readily be explained by binding of the antibody to the
cellular receptor for the factor. Inhibition could occur either as a result ofsteric
blockade of the factor's binding site or inducement ofa conformational change
that would alter the binding affinity for TCGF.
The results also indicate that the number of Tac proteins and TCGF receptors
on the surface of PHA-blasts are equal. In contrast, quantitative binding assays
demonstrated that, on a molar basis, ^-5-10 times more radiolabeled anti-Tac
antibody than radiolabeled TCGF was bound by such cells (W. Leonard, R.
Robb, and W. Greene, unpublished observations). This discrepancy could arise
for several reasons. First, although the specific activity of the radiolabeled probes
has been repeatedly verified, any systematic error in these values would directly
affect quantitativn of the binding site numbers. Second, the level of binding of
anti-Tac could be overestimated due to interaction with Fc receptors. Since
similar results were obtained with Fab fragments of the antibody, however, this
explanation is not applicable. Third, the TCGF-binding assay could underesti-
nlate the number ofreceptors ifa large portion were already occupied by factor.
This possibility also appears unlikely, however, since washing the cells at pH 4,
which has been shown to quantitatively elute bound radiolabeled TCGF (R.
Robb, unpublished observations), failed to significantly increase the subsequent
measurement of TCGF binding. Finally, the discrepancy could arise from a
difference in the affinity of the receptors for TCGF, similar to that found
recently for the receptor for epidermal growth factor (13). Ifa large portion of
the Tac antigens have a low affinity forTCGF, they would have gone undetected
in the original radiolabeled TCGF-binding assays (5), which were conducted at
low TCGF concentrations. Such a possibility would explain why sequential
incubations of radiolabeled cellular molecules with TCGF-coupled Affigel have
been consistently more effective than incubations with a single large aliquot of
beads. Also, it would provide one possible explanation for the observation (12)
that a large molar excess of TCGF is required to completely block the binding
of radiolabeled anti-Tac despite the fact that in the reciprocal experiment (Fig.
1), an excess ofanti-Tac was required to block the high affiuit), binding ofTCGF.1336
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FIGURE 2 .
￿
SDS-PAGE analysis (8.75% acrylamide with 2-mercaptoethanol) of radiolabeled
molecules from PHA-blast cells that were boundby the TCGF and anti-Tac affinity supports .
(A) [s5S]methionine-labeled cells with control IgG-coupled Sepharose/Affigel ; (B) [s5S]methi-
onine-labeled cells with anti-Tac-coupled Sepharose; (C) [s5S]methionine-labeled cells with
TCGF-coupled Affigel ; (D) [5H]glucosamine-labeled cells with control IgG-coupled Sepharose/
Affigel ; (E) ['H]glucosamine-labeled cells with anti-Tac-coupled Sepharose; (F) [sH]glucosa-
mine-labeled cells with TCGF-coupled Affigel . A similar band of slightly smaller size was
observed in each case when 2-mercaptoethanol was excluded .
The results presented here indicate that the 58,000 mol wt Tac antigen is a
cellular binding site forTCGF . This protein may constitute the intact receptor
or it may merely represent the binding site component of a larger, noncovalently
bonded molecular complex. Further characterization of the receptor should be
aided by TCGF-coupled supports, such as that described here, since the receptor
can be quantitatively recovered by low pH elution (R . Robb, unpublished
observations) . Moreover, in contrast to anti-Tac, which is limited to recognizing
the human receptor and that ofa few monkey species, TCGF-coupled supports
should be applicable to receptor purification in all species that are responsive to
human factor (i .e ., murine, rat, monkey, and guinea pig) .
Summary
Radiolabeled molecules from detergent-so]ubilized humanT cell blasts were
fractionated on affinity supports coupled with T cell growth factor (TCGF) and
anti-Tac antibody . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
analysis indicated that a glycoprotein of 58,000 mol wt was bound in both
cases . Sequential binding to the two affinity supports demonstrated that the
molecules recognized in each instance were identical . Thus, the Tac antigen
contains the cellular binding site forTCGF .
Note added in proof' : Preliminary binding experiments using high concentra-
tions of ['H]leucine, lysine TCGF with a low specific radioactivity indicate the
existence of a sizeable pool of receptor sites with an affinity 2,000-10,000 times
lower than that of the high affinity receptors measured in Fig . 1 . Such sites may
explain the numerical discrepancy between early TCGF binding experiments (5)
and the binding of the anti-Tac antibody . The hypothesis that the anti-TacROBB AND GREENE
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antibody apparently reacts with both classes of receptor would explain its effect
on the physiological response (high affinity binding) and the high level of Tac
antigen on the cell surface.
We wish to acknowledge the excellent technical assistance of L . Gehman.
Rereivedfor publication 28June 1983.
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